Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Sleep Initiation and Maintenance Disorders

fluorobenzenes has been researched along with Sleep Initiation and Maintenance Disorders in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bye, A; Ratti, E; Trist, DG1
Alexander, R; Archer, G; Carpenter, DJ; Danker-Hopfe, H; Fernandes, S; Merlo-Pich, E; Ratti, E; Robertson, J; Squassante, L; Trist, DG; Zamuner, S1
Everett, BM; Glynn, RJ; MacFadyen, J; Mora, S; Ridker, PM1
Dyer, C1
Miyamoto, M; Terao, A1
Monti, JM; Monti, L; Morales, F; Trenchi, HM1

Reviews

2 review(s) available for fluorobenzenes and Sleep Initiation and Maintenance Disorders

ArticleYear
Why receptor reserve matters for neurokinin1 (NK1) receptor antagonists.
    Journal of receptor and signal transduction research, 2013, Volume: 33, Issue:6

    Topics: Antidepressive Agents; Depressive Disorder, Major; Fluorobenzenes; Humans; Neurokinin-1 Receptor Antagonists; Piperazines; Piperidines; Receptors, Neurokinin-1; Sleep Initiation and Maintenance Disorders; Tissue Distribution

2013
[Recent and potential drugs for treatment of insomnia].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2007, Volume: 129, Issue:1

    Topics: Animals; Azabicyclo Compounds; Benzodiazepines; Diphenhydramine; Drug Design; Fluorobenzenes; GABA-A Receptor Agonists; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Indenes; Orexin Receptors; Phenols; Piperazines; Pyridines; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Serotonin 5-HT2 Receptor Antagonists; Sleep Initiation and Maintenance Disorders; Thiophenes; Zolpidem

2007

Trials

3 trial(s) available for fluorobenzenes and Sleep Initiation and Maintenance Disorders

ArticleYear
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.
    Sleep, 2013, Dec-01, Volume: 36, Issue:12

    Topics: Adult; Double-Blind Method; Female; Fluorobenzenes; Humans; Male; Middle Aged; Neurokinin-1 Receptor Antagonists; Piperidines; Polysomnography; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Young Adult

2013
Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER).
    The American journal of cardiology, 2014, Dec-01, Volume: 114, Issue:11

    Topics: Aged; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fluorobenzenes; Hematuria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Diseases; Male; Middle Aged; Odds Ratio; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Sleep Initiation and Maintenance Disorders; Sulfonamides; Treatment Outcome

2014
Flunitrazepam (Ro 5-4200) and sleep cycle in insomniac patients.
    Psychopharmacologia, 1974, Mar-09, Volume: 35, Issue:4

    Topics: Adult; Benzodiazepinones; Clinical Trials as Topic; Electroencephalography; Female; Fluorobenzenes; Humans; Hypnotics and Sedatives; Male; Middle Aged; Nitro Compounds; Placebos; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Time Factors

1974

Other Studies

1 other study(ies) available for fluorobenzenes and Sleep Initiation and Maintenance Disorders

ArticleYear
GP admits to falsifying clinical trial of insomnia drug.
    BMJ (Clinical research ed.), 2016, Apr-27, Volume: 353

    Topics: Clinical Trials as Topic; Drug Evaluation, Preclinical; Fluorobenzenes; General Practitioners; Humans; Male; Northern Ireland; Piperidines; Scientific Misconduct; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Treatment Outcome

2016